Venting Effects on Speech Performance

This study aims to gather behavioral data on the effect of earmold venting on speech performance in noise with a new noise reduction feature.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hearing Loss Ear Diseases Hearing Disorders Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Phonak Audiology Research Center

Aurora, Illinois, 60504, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Subjects fulfilling all of the following inclusion criteria are eligible for the investigation:

18-85 years of age
Experienced hearing aid users
N3-N4 hearing loss
Fluent in English; ability to read and write in English
Able to complete complex tasks
Willing and able to provide informed consent
Available for the data collection period

The presence of any one of the following exclusion criteria will lead to the exclusion of the subject:

Self-reported active ear-related pathology (otorrhea, dizziness, sudden hearing loss or worsening of hearing, otalgia)
Visible deformity of the ear
Chronic, severe tinnitus
Unilateral hearing loss
Cognitive impairment

Treatment and study plan

Phonak Audeo Infinio Hearing Aid

Device

Receiver-In-Canal hearing aid type that is coupled with either a custom earmold or a dome.

Primary outcomes

AZ Bio Sentences

Time frame: 1 day

Sentences will be presented at a pre-determined Signal-to-Noise Ratio (SNR). The SNR will be the same for all three conditions (Power dome, Vented dome, Open dome). Percent correct will be calculated for all conditions. A higher percentage indicates better performance.

Sponsors and collaborators

Lead sponsor

Sonova AG

Industry

Registry information

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Dec 2, 2024
Registry last updated: May 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed